Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
An announcement from Mayne Pharma Group ( (AU:MYX) ) is now available.
Mayne Pharma Group has announced that First Sentier Investors (Australia) IM Ltd has ceased to be a substantial holder in the company as of September 23, 2025. This change in substantial holding could impact the company’s shareholder structure and influence its market perception, as substantial holders often play a significant role in corporate governance and strategic decisions.
The most recent analyst rating on (AU:MYX) stock is a Buy with a A$6.10 price target. To see the full list of analyst forecasts on Mayne Pharma Group stock, see the AU:MYX Stock Forecast page.
More about Mayne Pharma Group
Average Trading Volume: 277,801
Technical Sentiment Signal: Sell
Current Market Cap: A$406.2M
Find detailed analytics on MYX stock on TipRanks’ Stock Analysis page.